DE2501122C3 - Amidoximderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel - Google Patents

Amidoximderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Info

Publication number
DE2501122C3
DE2501122C3 DE2501122A DE2501122A DE2501122C3 DE 2501122 C3 DE2501122 C3 DE 2501122C3 DE 2501122 A DE2501122 A DE 2501122A DE 2501122 A DE2501122 A DE 2501122A DE 2501122 C3 DE2501122 C3 DE 2501122C3
Authority
DE
Germany
Prior art keywords
methyl
benzofuryloxy
compounds
hydrochloride
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2501122A
Other languages
German (de)
English (en)
Other versions
DE2501122B2 (de
DE2501122A1 (de
Inventor
Pierre Luc Fontaine Eymard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Labaz Sa Paris Fr
Original Assignee
Labaz Sa Paris Fr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz Sa Paris Fr filed Critical Labaz Sa Paris Fr
Publication of DE2501122A1 publication Critical patent/DE2501122A1/de
Publication of DE2501122B2 publication Critical patent/DE2501122B2/de
Application granted granted Critical
Publication of DE2501122C3 publication Critical patent/DE2501122C3/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE2501122A 1974-01-15 1975-01-14 Amidoximderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel Expired DE2501122C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7401286A FR2257273B1 (US06174465-20010116-C00003.png) 1974-01-15 1974-01-15

Publications (3)

Publication Number Publication Date
DE2501122A1 DE2501122A1 (de) 1975-07-17
DE2501122B2 DE2501122B2 (de) 1981-05-21
DE2501122C3 true DE2501122C3 (de) 1982-03-18

Family

ID=9133487

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2501122A Expired DE2501122C3 (de) 1974-01-15 1975-01-14 Amidoximderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Country Status (23)

Country Link
US (1) US3931240A (US06174465-20010116-C00003.png)
JP (1) JPS541301B2 (US06174465-20010116-C00003.png)
AR (1) AR201414A1 (US06174465-20010116-C00003.png)
AT (1) AT340912B (US06174465-20010116-C00003.png)
BE (1) BE824227A (US06174465-20010116-C00003.png)
CA (1) CA1037960A (US06174465-20010116-C00003.png)
CH (1) CH593245A5 (US06174465-20010116-C00003.png)
DE (1) DE2501122C3 (US06174465-20010116-C00003.png)
DK (1) DK137953B (US06174465-20010116-C00003.png)
ES (1) ES433816A1 (US06174465-20010116-C00003.png)
FI (1) FI63746C (US06174465-20010116-C00003.png)
FR (1) FR2257273B1 (US06174465-20010116-C00003.png)
GB (1) GB1462311A (US06174465-20010116-C00003.png)
HU (1) HU168062B (US06174465-20010116-C00003.png)
IE (1) IE40883B1 (US06174465-20010116-C00003.png)
IT (1) IT1044267B (US06174465-20010116-C00003.png)
NL (1) NL166020C (US06174465-20010116-C00003.png)
NO (1) NO137894C (US06174465-20010116-C00003.png)
OA (1) OA04881A (US06174465-20010116-C00003.png)
SE (1) SE422202B (US06174465-20010116-C00003.png)
SU (1) SU545254A3 (US06174465-20010116-C00003.png)
YU (1) YU36495B (US06174465-20010116-C00003.png)
ZA (1) ZA748105B (US06174465-20010116-C00003.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2422630A1 (fr) * 1978-04-14 1979-11-09 Synthelabo Derives de propionamidoxime et leur application en therapeutique
FR2506767A1 (fr) 1981-05-26 1982-12-03 Synthelabo Derives heterocycliques d'amidoximes, leur preparation et leur application en therapeutique
FR2506764A1 (fr) * 1981-05-26 1982-12-03 Synthelabo Derives d'amidoximes, leur preparation et leur application en therapeutique
JPS58131482A (ja) * 1982-01-29 1983-08-05 Matsushita Electric Ind Co Ltd リフト型逆止弁
US4851554A (en) * 1987-04-06 1989-07-25 University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4806663A (en) * 1987-04-06 1989-02-21 The University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4831156A (en) * 1987-09-30 1989-05-16 The University Of Tennessee Research Corp. 3-substituted 2-alkyl indole derivatives
AU5257401A (en) * 2000-04-28 2001-11-12 Asahi Chemical Ind Novel bicyclic compounds

Also Published As

Publication number Publication date
NO750104L (US06174465-20010116-C00003.png) 1975-08-11
DK645174A (US06174465-20010116-C00003.png) 1975-09-08
ATA26875A (de) 1977-05-15
NL7500399A (nl) 1975-07-17
JPS541301B2 (US06174465-20010116-C00003.png) 1979-01-23
SE7500360L (US06174465-20010116-C00003.png) 1975-07-16
HU168062B (US06174465-20010116-C00003.png) 1976-02-28
AT340912B (de) 1978-01-10
ZA748105B (en) 1976-01-28
AR201414A1 (es) 1975-03-07
NL166020C (nl) 1981-06-15
FI63746B (fi) 1983-04-29
GB1462311A (en) 1977-01-26
ES433816A1 (es) 1976-09-16
SE422202B (sv) 1982-02-22
FR2257273A1 (US06174465-20010116-C00003.png) 1975-08-08
AU7665374A (en) 1976-06-24
CH593245A5 (US06174465-20010116-C00003.png) 1977-11-30
OA04881A (fr) 1980-10-31
NO137894C (no) 1978-05-24
NL166020B (nl) 1981-01-15
DK137953B (da) 1978-06-12
FI353674A (US06174465-20010116-C00003.png) 1975-07-16
JPS50101348A (US06174465-20010116-C00003.png) 1975-08-11
YU36495B (en) 1984-02-29
DE2501122B2 (de) 1981-05-21
NO137894B (no) 1978-02-06
BE824227A (fr) 1975-07-09
FI63746C (fi) 1983-08-10
DK137953C (US06174465-20010116-C00003.png) 1978-12-18
IE40883B1 (en) 1979-09-12
FR2257273B1 (US06174465-20010116-C00003.png) 1978-01-13
YU349874A (en) 1982-02-25
IT1044267B (it) 1980-03-20
US3931240A (en) 1976-01-06
IE40883L (en) 1975-07-15
DE2501122A1 (de) 1975-07-17
CA1037960A (en) 1978-09-05
SU545254A3 (ru) 1977-01-30

Similar Documents

Publication Publication Date Title
DE2711451C2 (US06174465-20010116-C00003.png)
DE1957706C3 (de) Kernsubstituierte 3-Phenoxy-l-phenoxyalkylamino-propan-2-ole und Arzneimittel auf deren Basis
DE2634288C3 (US06174465-20010116-C00003.png)
DE2809625A1 (de) Acetamidderivate und sie enthaltendes arzneimittel
DE1643262C3 (de) i-Phenoxy^-hydroxy-S-alklyaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD262226A5 (de) Verfahren zur herstellung von phenylalkylomin-derivaten
DE2041771B2 (de) derivate
DE2163911B2 (de) 2-Aminomethyl-phenole, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel
DD235065A5 (de) Verfahren zur herstellung von n-(2-(4-fluorphenyl)-1-methyl)-n-methyl-n-propinylamin
DE2501122C3 (de) Amidoximderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2707048A1 (de) Neue indolizinderivate, verfahren zu deren herstellung, sowie diese enthaltende zusammensetzungen
DE2638850C2 (de) 2-Amino-N↑1↑-(1-phenyl-2-methyl-2-propyl)-propionsäureamide, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
CH635312A5 (de) Alpha-aryl-alpha,alpha-bis(omega-(disubstituierte amino)-alkyl)acetamide und deren saeureanlagerungssalze, verfahren zu ihrer herstellung sowie sie enthaltende arzneimittelzubereitungen.
DE3112984A1 (de) 2-(3-(4-(3-chlor-4-fluorphenyl)-1-piperazinyl) propyl)-1,2,4-triazolo(4,3-a)pyridin-3(2h)-on dessen pharmazeutische anwendung und herstellung
DE2355262C3 (de) 1-Piperidinsulfonylharnstoffe, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
CH645368A5 (de) 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)benzoesaeure-derivate sowie verfahren zu deren herstellung.
DE2507429C2 (de) Aminosäureester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD141023A5 (de) Verfahren zur herstellung eines 2,3-dihydrobenzofuranderivats
DE2522218B2 (de) Zusammensetzung für die Human- oder Veterinärmedizin, Methylaminderivate und Verfahren zu deren Herstellung
DE2738131A1 (de) Aminoketone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
AT389872B (de) Verfahren zur herstellung von neuen substituierten 2-phenylmethylen-1aminoalkyloximinocycloalkanen und deren saeureadditionssalzen
DE2113489C3 (de) 2-Nitro-benzofuranderivate, ein Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE2023829C3 (de) Kernsubstituierte 3-Phenoxy-lphenoxyalkyl-amino-propan-2-oIe, Verfahren zu ihrer Herstellung sowie Arzneimittel
DE2227842C3 (de) Diphenylcyclopentane und diese enthaltende Arzneimittel
EP0035733B1 (de) Neue 1-(Acylamino-aryloxy-)2-hydroxy-3-alkinyl-aminopropane und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee